How Are Probiotics Assessed During Antibiotic Use?

How do antibiotics affect the gut microbiota?

The main purpose of antibiotics is to suppress or eliminate susceptible bacteria.

This effect may not be limited to disease-causing bacteria. The gut microbiota can also change depending on the antibiotic, dose, treatment duration and individual.

According to the ISAPP clinician resource, antibiotics may:

• reduce microbial diversity,
• reduce some microorganism groups while increasing others,
• alter the microbiome's functional properties,
• affect the selection of antibiotic-resistant microorganisms.[2]

The extent of these changes may differ between individuals.

Related article: What Is Gut Flora and Why Does It Matter?

What is antibiotic-associated diarrhoea?

During or after antibiotic use, some people may experience changes in stool consistency and frequency. This is called antibiotic-associated diarrhoea (AAD).

Several mechanisms may contribute to antibiotic-associated gastrointestinal changes, including altered microbiota and microbial metabolism, changes in colonisation resistance and conditions that favour the growth of certain microorganisms.[2][3]

One more severe clinical condition is diarrhoea associated with Clostridioides difficile, which requires medical assessment.

Why are probiotics studied during antibiotic use?

Probiotic research during antibiotic use focuses on two main areas: digestive comfort and gut microbiota functions.

1. Reducing clinical side effects

Clinical studies and meta-analyses of certain probiotic strains have reported benefits for outcomes such as antibiotic-associated diarrhoea.[1][2]

This is currently one of the strongest areas of clinical research.

2. Restoring the microbiota to its previous state

Changes in microbiota composition are assessed in relation to the strain used and the individual.

A 2025 expert review published in Nature Reviews Gastroenterology & Hepatology emphasises that current evidence does not show that probiotics restore antibiotic-altered microbiota to its pre-antibiotic state.[3]

Therefore:

Clinical benefit and microbiota recovery are different outcomes; research assesses them separately.

Considering these two subjects together allows a more accurate understanding of clinical benefit and microbiota recovery.

Which probiotic should be used with antibiotics?

Scientifically, the more useful question is “Which strain has been studied for which outcome?”

ISAPP emphasises that most probiotic benefits are species- and strain-specific, and that clinical selection should consider strains and doses tested in the relevant population.[2]

When presenting evidence for antibiotic-associated diarrhoea, WGO also lists specific strains and combinations rather than treating probiotics as a single group.[1]

For this reason:

• the selected strain identity,
• live microorganism count (CFU),
• strain count and dose are assessed alongside strain identity and clinical evidence.

Related article: What Is a Probiotic Strain? Are All Probiotics the Same?

How many hours should separate an antibiotic and a probiotic?

A commonly used practical approach is to leave approximately two hours between them; understanding the scientific basis for this interval matters.

According to the ISAPP clinician resource, many bacterial probiotics may be susceptible to various antibiotics. To reduce the likelihood of an antibiotic inactivating the probiotic, an interval of approximately two hours may be reasonable.[2]

The same resource notes that clinical research directly comparing different timing protocols is limited.[2] An interval of approximately two hours is therefore considered a reasonable approach used in current clinical practice.

Therefore:

An interval of approximately two hours is one reasonable timing approach used in practice for bacterial probiotics.

The product's directions and the healthcare professional's advice should guide use.

When should a probiotic be started?

In most studies showing benefits from probiotic use alongside antibiotics, probiotic administration began close to the start of antibiotic treatment.

The ISAPP resource states that, in studies showing efficacy, probiotic use generally began shortly before the antibiotic or within its first 1–2 days.[2]

Study start times vary by strain, dose and treatment duration, making the product's own directions important.

Should probiotics continue after antibiotics are finished?

Clinical research has used different protocols.

According to ISAPP, continuing for 7–14 days after antibiotic treatment ends is one commonly used research approach.[2]

In assessing this period,

• the strain and product used,
• the person's clinical condition,
• and the duration of antibiotic treatment

are considered together.

The duration should therefore be assessed in accordance with the product's directions and, where necessary, advice from a healthcare professional.

Do probiotics reduce an antibiotic's effect?

Current evidence does not show that probiotic use reduces the therapeutic effect of antibiotics.

The ISAPP clinician resource also states that there is no evidence supporting this concern.[2]

In this clinical context, probiotic use is considered a supportive approach alongside antibiotic treatment.

The prescribed antibiotic dose and duration should continue as planned; probiotic use is considered supportive alongside this treatment.

Decisions about medication belong to the physician.

What do scientific guidelines emphasise when selecting probiotics?

International gastroenterology and paediatric resources emphasise strain identity, the use studied, dose and age group when selecting probiotics.

Randomised trials and systematic reviews of antibiotic-associated diarrhoea have shown favourable clinical outcomes for some strains and combinations. These findings explain why probiotic support during antibiotic use is frequently studied. [1] [2]

For consumers, this means looking beyond the word “probiotic” to the strains included and the directions for use.

Evidence during antibiotic use for strains included in Enteromax

Some strains in the Enteromax formula have been assessed directly in human studies involving antibiotic use. These studies help explain the scientific background of those strains.

Lactobacillus acidophilus LA85

LA85 in the Enteromax formula, a human study directly matching the strain is available.

Chen and colleagues' randomised, double-blind, placebo-controlled study, published in 2025, assessed 82 adults receiving amoxicillin.[4]

In the overall intention-to-treat analysis:

• the rate of antibiotic-associated diarrhoea was 4.9% in the LA85 group and 14.6% in the placebo group,
• diarrhoea duration appeared shorter in the LA85 group,
• the two main comparisons in the overall ITT analysis remained at the trend level, while significant results were reported in fully adherent subgroups.[4]

Significant results were reported in some adherent subgroup analyses.

This study provides promising direct human data for LA85, which is included in Enteromax. The main comparisons in the overall cohort remained at the trend level, while significant results were reported in some adherent subgroups.[4]

Lacticaseibacillus rhamnosus LRa05

LRa05 also has direct human data in the context of an antibiotic-containing treatment.

Niu and colleagues' 2024 study assessed 71 H. pylori-positive adults receiving LRa05 or placebo during bismuth-containing quadruple eradication therapy.[5]

The LRa05 group showed improvements in gastrointestinal side effects such as:

• abdominal pain,
• bloating,
• reflux,
• watery stools

.[5]

In this study, LRa05's main contribution was seen in gastrointestinal tolerance rather than the eradication rate; supportive outcomes were reported for symptoms such as abdominal pain, bloating, reflux and watery stools.[5]

Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus

In Hickson and colleagues' 2007 study, a fermented milk combination containing L. bulgaricus, S. thermophilus and L. casei DN-114 001 was assessed in patients aged over 50 who were receiving antibiotics, and a reduction in antibiotic-associated diarrhoea was reported.[6]

Enteromax includes the BIO6744 and BIO1488 strains of these species. As the study assessed a combination of different strains, it provides biological background on these species in research during antibiotic use.

How can we support gut balance after antibiotics?

The gut microbiota may change temporarily during antibiotic use. Adequate fluid intake, a varied diet and appropriate probiotic support are parts of a holistic approach that considers digestive comfort during this period.

Research has shown favourable results for certain probiotic strains in the frequency of antibiotic-associated diarrhoea. In Enteromax Capsules, Lactobacillus acidophilus LA85 is one of the strains assessed in a directly matched human clinical study in this area. [4]

Considering strain identity, daily dose and the interval between probiotic and antibiotic use together can help make probiotic selection more informed.

How can probiotic support be tailored to the individual?

Probiotics are generally well tolerated in studies of healthy adults. During antibiotic use, strain selection, timing and the product's recommended daily dose are considered together.

People with severe immunosuppression, serious illness or specific medical circumstances such as an intravascular catheter should plan probiotic use with a physician. Bloody stools, high fever, severe abdominal pain or substantial fluid loss during antibiotic use require medical assessment.

Antibiotic treatment should continue as prescribed by the physician; probiotics are considered a supportive approach during this period.

Conclusion

In summary: Certain probiotic strains have been studied during antibiotic use for gastrointestinal tolerance and antibiotic-associated diarrhoea, with benefits shown in some studies.[1][2]

What this means in daily life: Probiotic selection becomes more meaningful when strain identity, dose, timing and personal health are considered together; an interval of approximately two hours may be a practical approach for bacterial probiotics.[2]

What research shows: Prescribed antibiotic treatment should continue as planned; probiotic use is considered supportive and should be assessed with a healthcare professional in specific risk groups.

Explore more: For a broader look at daily timing, you can read When Are Probiotics Used?

Information Note

This content is for general information and educational purposes. It is not a substitute for medical advice, diagnosis or treatment. Consult your physician or the relevant healthcare professional for an assessment of your personal health.

This content is for general information and educational purposes. It is not a substitute for medical advice, diagnosis or treatment. Do not change the dose, frequency or duration of a prescribed antibiotic because you are using a probiotic. Consult your physician or the relevant healthcare professional for an individual assessment of antibiotic treatment and concurrent supplement use.